首页 > 最新文献

Precision Radiation Oncology最新文献

英文 中文
Anlotinib helps alleviate radiation pneumonitis: A case report 安洛替尼有助于减轻放射性肺炎:一例报告
Q4 Medicine Pub Date : 2021-12-01 DOI: 10.1002/pro6.1139
Jiazhen Chen, Cunliang Wang, Xudong Hu
Radiation pneumonitis is a serious side effect of thoracic radiotherapy with no established treatment currently. Anlotinib is a small‐molecule tyrosine kinase inhibitor (TKI) with anti‐angiogenic effects. The effect of TKIs in the treatment of radiation pneumonitis remains to be elucidated. We investigated whether anlotinib could alleviate radiation pneumonitis. We report a case of a patient with esophageal cancer who received anlotinib for radiation pneumonitis following radiotherapy. We also reviewed related studies to address this issue. The results in this patient suggest that anlotinib may be a valid treatment option for radiation pneumonitis.
放射性肺炎是胸部放射治疗的严重副作用,目前尚无确定的治疗方法。安洛替尼是一种具有抗血管生成作用的小分子酪氨酸激酶抑制剂(TKI)。TKIs在治疗放射性肺炎中的作用仍有待阐明。我们研究了安洛替尼是否能减轻放射性肺炎。我们报告一例癌症食管癌患者在放疗后接受安洛替尼治疗放射性肺炎。我们还审查了解决这一问题的相关研究。该患者的研究结果表明,安洛替尼可能是治疗放射性肺炎的有效选择。
{"title":"Anlotinib helps alleviate radiation pneumonitis: A case report","authors":"Jiazhen Chen, Cunliang Wang, Xudong Hu","doi":"10.1002/pro6.1139","DOIUrl":"https://doi.org/10.1002/pro6.1139","url":null,"abstract":"Radiation pneumonitis is a serious side effect of thoracic radiotherapy with no established treatment currently. Anlotinib is a small‐molecule tyrosine kinase inhibitor (TKI) with anti‐angiogenic effects. The effect of TKIs in the treatment of radiation pneumonitis remains to be elucidated. We investigated whether anlotinib could alleviate radiation pneumonitis. We report a case of a patient with esophageal cancer who received anlotinib for radiation pneumonitis following radiotherapy. We also reviewed related studies to address this issue. The results in this patient suggest that anlotinib may be a valid treatment option for radiation pneumonitis.","PeriodicalId":32406,"journal":{"name":"Precision Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48272919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Status of radiotherapy staff during the coronavirus disease 2019 (COVID-19) epidemic in China. 2019冠状病毒病(COVID-19)在中国流行期间放疗人员的状况
Q4 Medicine Pub Date : 2021-11-08 eCollection Date: 2021-12-01 DOI: 10.1002/pro6.1134
Hui Wang, Lulu Chen, Zheming Liu, Ping Li, Tangpeng Xu, Zhenmin Fu, Qibin Song, Hongxue Wu, Xiangpan Li

Objective: In December 2019, coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) broke out in Wuhan, China. The pandemic has posed a great challenge to radiation oncology departments, as interruptions in radiation therapy (RT) increase the risks of cancer recurrence or failure of the therapy as a whole. This study aimed to elucidate the impact of COVID-19 on radiation therapy staff in China.

Methods: As many working staff at different radiation oncology departments in China as possible were retrospectively enrolled from 23 January to 9 March 2020. They were then invited to answer a questionnaire, for essential data collection, from which their basic information, anxiety level, and workload were analyzed.

Results: Seven (0.39%) of the 1 755 radiation therapy staff who answered the questionnaire had contracted COVID-19, all of whom were from Wuhan. The factors influencing susceptibility were not sex (P  =  1.000), age (P  =  0.480), or comorbidities (P  =  0.600), but geographic location (P < 0.001) and whether the respondent worked in a designated COVID-19 hospital (P  =  0.003). In terms of protection procedures, four participants carried out basic, one second-level and two third-level protection procedures. The difference was not statistically significant (P  =  0.720). The infected respondents' anxiety level related to the outbreak (average score 6.57) was higher than that of their counterparts in Wuhan (5.18), as well as across the country (4.79), and 71.43% of those infected expressed the need for psychological interventions. During the epidemic, departments of 428 respondents (24.39%) shut down, while 76.71% of the respondents reported workload reduction.

Conclusion: The factors related to COVID-19 infection were the geographic location and whether the respondent worked in a designated COVID-19 hospital. The infected respondents experienced greater psychological pressure than their uninfected counterparts and, therefore, required more psychological interventions.

目的:2019年12月,由严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)引起的冠状病毒病2019 (COVID-19)在中国武汉暴发。大流行给放射肿瘤学部门带来了巨大挑战,因为放射治疗(RT)的中断增加了癌症复发或整体治疗失败的风险。本研究旨在阐明COVID-19对中国放射治疗人员的影响。方法:在2020年1月23日至3月9日期间,回顾性招募尽可能多的中国不同放射肿瘤科的工作人员。然后,他们被邀请回答一份问卷,以收集基本数据,从中分析他们的基本信息、焦虑水平和工作量。结果:1 755名接受调查的放射治疗人员中,有7名(0.39%)感染了COVID-19,全部来自武汉市。影响易感性的因素不是性别(P = 1.000)、年龄(P = 0.480)或合并症(P = 0.600),而是地理位置(P = 0.003)。在保护程序方面,4名参与者进行了基本保护程序,1名进行了二级保护程序,2名进行了三级保护程序。差异无统计学意义(P = 0.720)。感染人群与疫情相关的焦虑水平(平均得分6.57分)高于武汉市(5.18分)和全国(4.79分),71.43%的感染人群表示需要心理干预。疫情期间,428个被调查单位(24.39%)的部门关闭,76.71%的被调查单位表示工作量减少。结论:与COVID-19感染相关的因素是地理位置和被调查者是否在COVID-19定点医院工作。受感染的应答者比未受感染的应答者承受更大的心理压力,因此需要更多的心理干预。
{"title":"Status of radiotherapy staff during the coronavirus disease 2019 (COVID-19) epidemic in China.","authors":"Hui Wang,&nbsp;Lulu Chen,&nbsp;Zheming Liu,&nbsp;Ping Li,&nbsp;Tangpeng Xu,&nbsp;Zhenmin Fu,&nbsp;Qibin Song,&nbsp;Hongxue Wu,&nbsp;Xiangpan Li","doi":"10.1002/pro6.1134","DOIUrl":"https://doi.org/10.1002/pro6.1134","url":null,"abstract":"<p><strong>Objective: </strong>In December 2019, coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) broke out in Wuhan, China. The pandemic has posed a great challenge to radiation oncology departments, as interruptions in radiation therapy (RT) increase the risks of cancer recurrence or failure of the therapy as a whole. This study aimed to elucidate the impact of COVID-19 on radiation therapy staff in China.</p><p><strong>Methods: </strong>As many working staff at different radiation oncology departments in China as possible were retrospectively enrolled from 23 January to 9 March 2020. They were then invited to answer a questionnaire, for essential data collection, from which their basic information, anxiety level, and workload were analyzed.</p><p><strong>Results: </strong>Seven (0.39%) of the 1 755 radiation therapy staff who answered the questionnaire had contracted COVID-19, all of whom were from Wuhan. The factors influencing susceptibility were not sex (<i>P</i>  =  1.000), age (<i>P</i>  =  0.480), or comorbidities (<i>P</i>  =  0.600), but geographic location (<i>P</i> < 0.001) and whether the respondent worked in a designated COVID-19 hospital (<i>P</i>  =  0.003). In terms of protection procedures, four participants carried out basic, one second-level and two third-level protection procedures. The difference was not statistically significant (<i>P</i>  =  0.720). The infected respondents' anxiety level related to the outbreak (average score 6.57) was higher than that of their counterparts in Wuhan (5.18), as well as across the country (4.79), and 71.43% of those infected expressed the need for psychological interventions. During the epidemic, departments of 428 respondents (24.39%) shut down, while 76.71% of the respondents reported workload reduction.</p><p><strong>Conclusion: </strong>The factors related to COVID-19 infection were the geographic location and whether the respondent worked in a designated COVID-19 hospital. The infected respondents experienced greater psychological pressure than their uninfected counterparts and, therefore, required more psychological interventions.</p>","PeriodicalId":32406,"journal":{"name":"Precision Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5d/17/PRO6-5-222.PMC8661947.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39839529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is gamma knife radiosurgery for skull base meningiomas with carotid artery encasement supported by efficacy and safety outcomes? 伽玛刀治疗颈动脉包裹的颅底脑膜瘤是否有疗效和安全性结果支持?
Q4 Medicine Pub Date : 2021-10-13 DOI: 10.1002/pro6.1132
F. Ampil, A. Sin, Donald R. Smith
Clinical outcomes were reviewed in 30 patients treated by gamma knife radiosurgery for skull base meningiomas with carotid artery encasement (SKBM‐CAE). The overall clinical improvement rate after treatment was 46%. At a median imaging follow‐up of 49 months, tumor volumes were unchanged, were larger, and were smaller or had resolved in 70%, 23%, and 7% of cases, respectively. The crude survival rate at 10 years was 20% and the complication (new cranial nerve deficit not accompanied by imaging‐shown tumor growth) rate was 10%. SKBM‐CAE is amenable to being effectively and safely controlled with the application of gamma knife radiosurgery.
回顾了30例接受伽玛刀治疗颈动脉包裹的颅底脑膜瘤(SKBM-CAE)的临床结果。治疗后的总体临床改善率为46%。中位影像学随访49个月时,肿瘤体积不变、较大、较小或已消退的病例分别为70%、23%和7%。10年的粗生存率为20%,并发症(新的脑神经缺损不伴有影像学显示的肿瘤生长)发生率为10%。SKBM-CAE可通过伽玛刀放射外科的应用得到有效和安全的控制。
{"title":"Is gamma knife radiosurgery for skull base meningiomas with carotid artery encasement supported by efficacy and safety outcomes?","authors":"F. Ampil, A. Sin, Donald R. Smith","doi":"10.1002/pro6.1132","DOIUrl":"https://doi.org/10.1002/pro6.1132","url":null,"abstract":"Clinical outcomes were reviewed in 30 patients treated by gamma knife radiosurgery for skull base meningiomas with carotid artery encasement (SKBM‐CAE). The overall clinical improvement rate after treatment was 46%. At a median imaging follow‐up of 49 months, tumor volumes were unchanged, were larger, and were smaller or had resolved in 70%, 23%, and 7% of cases, respectively. The crude survival rate at 10 years was 20% and the complication (new cranial nerve deficit not accompanied by imaging‐shown tumor growth) rate was 10%. SKBM‐CAE is amenable to being effectively and safely controlled with the application of gamma knife radiosurgery.","PeriodicalId":32406,"journal":{"name":"Precision Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43372487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of refractory mycetoma by radiotherapy: a case study and review 放射治疗难治性霉菌瘤1例报告
Q4 Medicine Pub Date : 2021-09-01 DOI: 10.1002/pro6.1125
Anil Gupta, D. Sharma, Somesh Gupta, Seema Sharma, T. Dev, Suvesh Singh, R. Mücke, O. Micke
Mycetoma is a localized chronic subcutaneous infection caused by fungi. It is clinically characterized by a triad of tumefaction, sinuses, and discharge containing typical grains. Eumycetoma, a subtype, is characterized by a low cure rate. Long‐term medication and surgical excision are required to treat the infection. Radiotherapy, a less used modality of treatment, may provide a good salvage option for refractory eumycetoma. Herein, we present a case and a review of the literature of refractory eumycetoma of the foot where radiotherapy was used as a salvage treatment. In the present case, a dose of 17.5 Gy in five fractions was delivered, and the response was assessed as per the Response Evaluation Criteria in Solid Tumors 1.1, discharging grains status, and Dermatology Life Quality Index. The literature on the use of radiotherapy for mycetoma was found to be scanty. In the present case with radiotherapy, there was a partial radiological response, resolution of discharging grains, and improvement in the Dermatology Life Quality Index score. However, the benefit was short‐lived, but re‐irradiation and low‐dose radiotherapy resulted in sustained benefits until 15 months of follow up. The antiproliferative and anti‐inflammatory actions of radiotherapy can be exploited in the treatment of rare, medically difficult to treat mycetoma. This case report may serve as a basis for further evaluation.
Mycetoma是一种由真菌引起的局部慢性皮下感染。它的临床特征是肿胀、鼻窦和含有典型颗粒的分泌物。真菌瘤是一种亚型,其特点是治愈率低。需要长期药物治疗和手术切除来治疗感染。放射治疗是一种较少使用的治疗方式,可能为难治性真菌瘤提供一个很好的挽救选择。在此,我们提出了一个病例,并回顾了文献中的难治性足真菌瘤,其中放射治疗是一种挽救治疗。在本例中,分五个部分给予17.5 Gy的剂量,并根据实体瘤反应评估标准1.1、排出颗粒状态和皮肤病学生活质量指数评估反应。关于放射治疗霉菌瘤的文献很少。在目前的放射治疗病例中,出现了部分放射反应,排出颗粒物得到了解决,皮肤科生活质量指数得分有所改善。然而,这种益处是短暂的,但再次照射和低剂量放射治疗带来了持续的益处,直到随访15个月。放射治疗的抗增殖和抗炎作用可用于治疗罕见的、医学上难以治疗的霉菌瘤。本案例报告可作为进一步评估的依据。
{"title":"Treatment of refractory mycetoma by radiotherapy: a case study and review","authors":"Anil Gupta, D. Sharma, Somesh Gupta, Seema Sharma, T. Dev, Suvesh Singh, R. Mücke, O. Micke","doi":"10.1002/pro6.1125","DOIUrl":"https://doi.org/10.1002/pro6.1125","url":null,"abstract":"Mycetoma is a localized chronic subcutaneous infection caused by fungi. It is clinically characterized by a triad of tumefaction, sinuses, and discharge containing typical grains. Eumycetoma, a subtype, is characterized by a low cure rate. Long‐term medication and surgical excision are required to treat the infection. Radiotherapy, a less used modality of treatment, may provide a good salvage option for refractory eumycetoma. Herein, we present a case and a review of the literature of refractory eumycetoma of the foot where radiotherapy was used as a salvage treatment. In the present case, a dose of 17.5 Gy in five fractions was delivered, and the response was assessed as per the Response Evaluation Criteria in Solid Tumors 1.1, discharging grains status, and Dermatology Life Quality Index. The literature on the use of radiotherapy for mycetoma was found to be scanty. In the present case with radiotherapy, there was a partial radiological response, resolution of discharging grains, and improvement in the Dermatology Life Quality Index score. However, the benefit was short‐lived, but re‐irradiation and low‐dose radiotherapy resulted in sustained benefits until 15 months of follow up. The antiproliferative and anti‐inflammatory actions of radiotherapy can be exploited in the treatment of rare, medically difficult to treat mycetoma. This case report may serve as a basis for further evaluation.","PeriodicalId":32406,"journal":{"name":"Precision Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44945738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dosimetric validation of two different radiobiological models for parotid gland functionality of tongue cancer 两种不同放射生物学模型对舌癌症腮腺功能的剂量验证
Q4 Medicine Pub Date : 2021-09-01 DOI: 10.1002/pro6.1130
S. Pramanik, S. Bera, Sanjoy Roy, A. Ray, S. Sarkar, D. Majumder
The aim of this study was to investigate the normal tissue complication probability (NTCP) for parotid gland of ca tongue patients from two different radiobiological models and to establish a dosimetric validity.
本研究的目的是从两种不同的放射生物学模型中研究卡舌腮腺患者的正常组织并发症概率(NTCP),并建立剂量测定的有效性。
{"title":"Dosimetric validation of two different radiobiological models for parotid gland functionality of tongue cancer","authors":"S. Pramanik, S. Bera, Sanjoy Roy, A. Ray, S. Sarkar, D. Majumder","doi":"10.1002/pro6.1130","DOIUrl":"https://doi.org/10.1002/pro6.1130","url":null,"abstract":"The aim of this study was to investigate the normal tissue complication probability (NTCP) for parotid gland of ca tongue patients from two different radiobiological models and to establish a dosimetric validity.","PeriodicalId":32406,"journal":{"name":"Precision Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49442457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Guidelines for radiotherapy of nasopharyngeal carcinoma 鼻咽癌放射治疗指南
Q4 Medicine Pub Date : 2021-09-01 DOI: 10.1002/pro6.1123
Rensheng Wang, Min Kang
With the extensive application of intensity‐modulated conformal radiotherapy and the deepening of the concept of comprehensive treatment, the therapeutic effect of nasopharyngeal carcinoma and the quality of life of patients have been significantly improved. However, guidelines for radiotherapy of nasopharyngeal carcinoma in China are in short supply. Dozens of experts from the Radiation Oncology Physicians Branch of the Chinese Medical Doctor Association and the Radiation Oncology Branch of the Chinese Medical Association have developed the publication Guidelines for radiotherapy of nasopharyngeal carcinoma in China after discussion. The guidelines include the epidemiology, diagnosis, clinical stage, treatment principle, and treatment of complications of radiotherapy of nasopharyngeal carcinoma. Importantly, the procedure of radiotherapy for nasopharyngeal carcinoma has been developed, which covers the imaging of nasopharyngeal carcinoma, radiotherapy localization, target area delineation, dose limitation, and plan evaluation. The guidelines will help to realize the homogenization of the diagnosis and treatment of nasopharyngeal carcinoma among radiotherapeutic medical staff in different levels of hospitals in China, thereby improving the overall level of diagnosis and treatment of nasopharyngeal carcinoma in China.
随着调强适形放疗的广泛应用和综合治疗理念的深化,鼻咽癌的治疗效果和患者的生活质量得到了显著提高。然而,中国的鼻咽癌放射治疗指南却供不应求。来自中国医师协会放射肿瘤学医师分会和中华医学会放射肿瘤学分会的数十位专家经过讨论,制定了《中国鼻咽癌放射治疗指南》。该指南包括鼻咽癌的流行病学、诊断、临床分期、治疗原则和放疗并发症的治疗。重要的是,已经开发了鼻咽癌放射治疗程序,包括鼻咽癌的成像、放射定位、靶区划定、剂量限制和计划评估。该指南将有助于实现我国各级医院放射治疗医务人员鼻咽癌诊疗的同质化,从而提高我国鼻咽癌诊疗的整体水平。
{"title":"Guidelines for radiotherapy of nasopharyngeal carcinoma","authors":"Rensheng Wang, Min Kang","doi":"10.1002/pro6.1123","DOIUrl":"https://doi.org/10.1002/pro6.1123","url":null,"abstract":"With the extensive application of intensity‐modulated conformal radiotherapy and the deepening of the concept of comprehensive treatment, the therapeutic effect of nasopharyngeal carcinoma and the quality of life of patients have been significantly improved. However, guidelines for radiotherapy of nasopharyngeal carcinoma in China are in short supply. Dozens of experts from the Radiation Oncology Physicians Branch of the Chinese Medical Doctor Association and the Radiation Oncology Branch of the Chinese Medical Association have developed the publication Guidelines for radiotherapy of nasopharyngeal carcinoma in China after discussion. The guidelines include the epidemiology, diagnosis, clinical stage, treatment principle, and treatment of complications of radiotherapy of nasopharyngeal carcinoma. Importantly, the procedure of radiotherapy for nasopharyngeal carcinoma has been developed, which covers the imaging of nasopharyngeal carcinoma, radiotherapy localization, target area delineation, dose limitation, and plan evaluation. The guidelines will help to realize the homogenization of the diagnosis and treatment of nasopharyngeal carcinoma among radiotherapeutic medical staff in different levels of hospitals in China, thereby improving the overall level of diagnosis and treatment of nasopharyngeal carcinoma in China.","PeriodicalId":32406,"journal":{"name":"Precision Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48994167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Multiple severe late adverse effects after definitive chemoradiation for locally advanced cervical cancer 局部晚期宫颈癌明确放化疗后的多重严重晚期不良反应
Q4 Medicine Pub Date : 2021-09-01 DOI: 10.1002/pro6.1126
C. Danko, L. Hong, J. Slater
Concurrent chemoradiation is the standard of care for locally advanced cervical cancer and is commonly associated with mild to moderate toxicities. Severe late complications in multiple organ systems in patients without known patient‐ or treatment‐related risk factors are rare. A 42‐year‐old woman was treated with definitive chemoradiotherapy with external beam radiotherapy and brachytherapy. She had complete resolution of the disease, with no evidence of recurrence. However, she experienced late morbidity in multiple organ systems due to treatment, likely indicating an increased sensitivity to radiation. This case highlights the need for improvements in the identification of such patients.
同期放化疗是局部晚期宫颈癌症的标准治疗,通常与轻度至中度毒性有关。在没有已知患者或治疗相关风险因素的患者中,多器官系统的严重晚期并发症是罕见的。一名42岁的女性接受了明确的放化疗,包括外束放射治疗和近距离放射治疗。她已完全痊愈,没有复发的迹象。然而,由于治疗,她经历了多器官系统的晚期发病,这可能表明她对辐射的敏感性增加。这一案例凸显了在识别此类患者方面需要改进的地方。
{"title":"Multiple severe late adverse effects after definitive chemoradiation for locally advanced cervical cancer","authors":"C. Danko, L. Hong, J. Slater","doi":"10.1002/pro6.1126","DOIUrl":"https://doi.org/10.1002/pro6.1126","url":null,"abstract":"Concurrent chemoradiation is the standard of care for locally advanced cervical cancer and is commonly associated with mild to moderate toxicities. Severe late complications in multiple organ systems in patients without known patient‐ or treatment‐related risk factors are rare. A 42‐year‐old woman was treated with definitive chemoradiotherapy with external beam radiotherapy and brachytherapy. She had complete resolution of the disease, with no evidence of recurrence. However, she experienced late morbidity in multiple organ systems due to treatment, likely indicating an increased sensitivity to radiation. This case highlights the need for improvements in the identification of such patients.","PeriodicalId":32406,"journal":{"name":"Precision Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/pro6.1126","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49106793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mediastinal and neck follicular dendritic cell sarcoma treated with definitive radiation therapy using the volumetric modulated arc therapy technique: a case report 纵隔和颈部滤泡树突状细胞肉瘤用体积调制弧线治疗:1例报告
Q4 Medicine Pub Date : 2021-09-01 DOI: 10.1002/pro6.1124
Adnan Calcuttawala, Nilesh Deshmane, Jaydeep N Pol, Sharad Desai
Follicular dendritic cell sarcoma (FDCS) is a rare malignancy that affects the nodal and extranodal tissues. The mediastinum is a rare site for this tumor, with few published reports and series. Although surgery is the mainstay of treatment for this disease entity, in this report we present a case of mediastinal FDCS treated with definitive radiation therapy (RT) with a near‐total radiological response. A 28‐year‐old woman presented with chest tightness and neck swelling. Radiological findings were suggestive of a conglomerated nodal mass involving the mediastinum and extending superiorly into the anterior neck. Biopsy results led to a diagnosis of FDCS. The tumor was deemed unresectable, and definitive RT was planned as the treatment. The patient was treated with volumetric modulated arc therapy to a total dose of 54 Gy in 30 fractions over 6 weeks. Her symptoms had completely resolved at the first follow‐up visit, 3 months after RT completion, with a near‐total radiological response on a contrast‐enhanced computed tomography scan. Although surgery is the standard of care in FDCS, based on the favorable response of FDCS to RT, as in this case, the role of definitive RT needs to be studied in more patients to determine its efficacy in long‐term tumor control as an alternative to surgery.
滤泡树突状细胞肉瘤(FDCS)是一种罕见的恶性肿瘤,影响淋巴结和结外组织。纵隔是这种肿瘤的罕见部位,很少有发表的报道和系列报道。尽管手术是治疗这种疾病的主要手段,但在本报告中,我们介绍了一例纵隔FDCS患者,该患者接受了明确的放射治疗(RT),具有近乎完全的放射反应。一名28岁女性出现胸闷和颈部肿胀。放射学检查结果提示纵隔内有一个结节性肿块,向上延伸至颈部前部。活检结果诊断为FDCS。肿瘤被认为是不可切除的,并计划进行明确的RT治疗。患者在6周内接受体积调制电弧治疗,总剂量为54Gy,分为30个部分。在RT完成3个月后的第一次随访中,她的症状已经完全缓解,对比增强计算机断层扫描显示几乎完全的放射学反应。尽管手术是FDCS的标准护理,但基于FDCS对RT的良好反应,如本例所示,需要在更多患者中研究明确RT的作用,以确定其作为手术替代方案在长期肿瘤控制中的疗效。
{"title":"Mediastinal and neck follicular dendritic cell sarcoma treated with definitive radiation therapy using the volumetric modulated arc therapy technique: a case report","authors":"Adnan Calcuttawala, Nilesh Deshmane, Jaydeep N Pol, Sharad Desai","doi":"10.1002/pro6.1124","DOIUrl":"https://doi.org/10.1002/pro6.1124","url":null,"abstract":"Follicular dendritic cell sarcoma (FDCS) is a rare malignancy that affects the nodal and extranodal tissues. The mediastinum is a rare site for this tumor, with few published reports and series. Although surgery is the mainstay of treatment for this disease entity, in this report we present a case of mediastinal FDCS treated with definitive radiation therapy (RT) with a near‐total radiological response. A 28‐year‐old woman presented with chest tightness and neck swelling. Radiological findings were suggestive of a conglomerated nodal mass involving the mediastinum and extending superiorly into the anterior neck. Biopsy results led to a diagnosis of FDCS. The tumor was deemed unresectable, and definitive RT was planned as the treatment. The patient was treated with volumetric modulated arc therapy to a total dose of 54 Gy in 30 fractions over 6 weeks. Her symptoms had completely resolved at the first follow‐up visit, 3 months after RT completion, with a near‐total radiological response on a contrast‐enhanced computed tomography scan. Although surgery is the standard of care in FDCS, based on the favorable response of FDCS to RT, as in this case, the role of definitive RT needs to be studied in more patients to determine its efficacy in long‐term tumor control as an alternative to surgery.","PeriodicalId":32406,"journal":{"name":"Precision Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/pro6.1124","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41827852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Consideration of the target area of radiotherapy for lung cancer with 4DPET 4DPET对肺癌放疗靶区的探讨
Q4 Medicine Pub Date : 2021-09-01 DOI: 10.1002/pro6.1131
Zhang Yanlan, L. Xianfeng, Huang Lingjun
Through the study of 4‐dimensional (4D) positron emission tomography (PET)/computed tomography (CT) for lung tumor, the delineation of the lung tumor target area was analyzed, the accurate target area was received, and the radiation dose of normal tissue was compared .
通过对肺肿瘤的4维(4D)正电子发射断层扫描(PET)/计算机断层扫描(CT)的研究,分析肺肿瘤靶区的划定,获得准确靶区,并比较正常组织的辐射剂量。
{"title":"Consideration of the target area of radiotherapy for lung cancer with 4DPET","authors":"Zhang Yanlan, L. Xianfeng, Huang Lingjun","doi":"10.1002/pro6.1131","DOIUrl":"https://doi.org/10.1002/pro6.1131","url":null,"abstract":"Through the study of 4‐dimensional (4D) positron emission tomography (PET)/computed tomography (CT) for lung tumor, the delineation of the lung tumor target area was analyzed, the accurate target area was received, and the radiation dose of normal tissue was compared .","PeriodicalId":32406,"journal":{"name":"Precision Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41552845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guidelines for radiotherapy of prostate cancer (2020 edition) 癌症放射治疗指南(2020年版)
Q4 Medicine Pub Date : 2021-09-01 DOI: 10.1002/pro6.1129
Gaofeng Li, Yexiong Li, Junjie Wang, Xian-shu Gao, Q. Zhong, Liru He, Chunmei Li, Ming Liu, Yueping Liu, M. Ma, Hao Wang, Xuan Wang, Hui Zhu
In recent years, the incidence of prostate cancer in China has shown a trend of continuous growth. Prostate cancer has become a urinary malignant tumor that seriously affects the health of men in China. Radical surgery and precision radiotherapy are the main methods of radical treatment for prostate cancer. Standardized diagnosis and treatment via a multidisciplinary team should be the standard practice to improve cure rate. Rapid development in imaging, pathology and molecular gene diagnosis has significantly changed the management of prostate cancer. In radiation oncology, image‐guided intensity modulated radiotherapy has been widely adopted in the treatment of prostate cancer. The comprehensive approach centered with radiotherapy has achieved excellent curative effect while continuously reducing treatment‐related side effects.
近年来,我国前列腺癌癌症的发病率呈现持续增长的趋势。癌症已成为我国严重影响男性健康的泌尿系恶性肿瘤。根治性手术和精确放疗是癌症根治性治疗的主要方法。通过多学科团队进行标准化诊断和治疗应该是提高治愈率的标准做法。影像学、病理学和分子基因诊断的快速发展已经显著改变了癌症的治疗。在放射肿瘤学中,图像引导强度调制放疗已被广泛用于治疗癌症前列腺。以放射治疗为中心的综合治疗方法取得了良好的疗效,同时不断减少与治疗相关的副作用。
{"title":"Guidelines for radiotherapy of prostate cancer (2020 edition)","authors":"Gaofeng Li, Yexiong Li, Junjie Wang, Xian-shu Gao, Q. Zhong, Liru He, Chunmei Li, Ming Liu, Yueping Liu, M. Ma, Hao Wang, Xuan Wang, Hui Zhu","doi":"10.1002/pro6.1129","DOIUrl":"https://doi.org/10.1002/pro6.1129","url":null,"abstract":"In recent years, the incidence of prostate cancer in China has shown a trend of continuous growth. Prostate cancer has become a urinary malignant tumor that seriously affects the health of men in China. Radical surgery and precision radiotherapy are the main methods of radical treatment for prostate cancer. Standardized diagnosis and treatment via a multidisciplinary team should be the standard practice to improve cure rate. Rapid development in imaging, pathology and molecular gene diagnosis has significantly changed the management of prostate cancer. In radiation oncology, image‐guided intensity modulated radiotherapy has been widely adopted in the treatment of prostate cancer. The comprehensive approach centered with radiotherapy has achieved excellent curative effect while continuously reducing treatment‐related side effects.","PeriodicalId":32406,"journal":{"name":"Precision Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48971492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
期刊
Precision Radiation Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1